COVID-19 and Children
As part of its partnership with the National Institutes of Health-funded RECOVER initiative, Robert Wood Johnson Medical School will receive $30 million to study long-term and delayed impacts of COVID-19 in children and lead a national collaboration to investigate these outcomes. “Children and adolescents are susceptible to long-term symptoms,” says Lawrence Kleinman, a professor and vice chair in the Department of Pediatrics at the medical school and professor of urban global health at the School of Public Health. “We are still learning what long COVID may look like in children as well as in adults.” Kleinman RC’79 is the lead investigator for the Collaborative Long-term study of Outcomes of COVID-19 in Kids (CLOCK) consortium at Rutgers.